- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT04206852
Säkerhet och effektivitet av ballongpulmonell angioplastik i Kina
Balloon pulmonary angioplasty (BPA) is a potential treatment for patients with pulmonary artery stenosis, including non-operable patients with chronic thromboembolic pulmonary hypertension (CTEPH), takayasu arteritis and fibrosis mediastinitis.
The aim of this study was to evaluate the safety and efficacy of BPA in CTEPH and patients not amenable to pulmonary endarterectomy(PEA) or suffered from persistent CTEPH after PEA, , takayasu arteritis and fibrosis mediastinitis.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
This study is a prospective, multi-center, long-term observational project to study the safety and efficacy of BPA. Clinical evaluation, including: functional capacity, 6-minutes walking test, biomarkers, cardiopulmonary exercise test, electrocardiography, echocardiography, haemodynamics, pulmonary angiography and lung scintigraphy was performed before the initiation therapy of BPA, and 3-12 months after last session of BPA.
we also aim to evaluate the value of FAPI in predicting the efficacy and the prognosis of patients with CTEPH who received BPA.
Studietyp
Inskrivning (Beräknad)
Kontakter och platser
Studiekontakt
- Namn: Zhihong Liu, doctor
- Telefonnummer: 8601088396985
- E-post: zhihongliufuwai@163.com
Studieorter
-
-
-
Beijing, Kina, 100037
- Rekrytering
- center of pulmonary vascular disease, Fuwai hospital
-
Kontakt:
- Zhihong Liu, doctor
- Telefonnummer: 8601088396816
- E-post: zhihongliufuwai@163.com
-
Huvudutredare:
- Zhihong Liu, MD,PhD
-
Beijing, Kina, 100037
- Rekrytering
- Chinese Academy of Medical Sciences Fuwai hospital
-
Kontakt:
- Zhao zhihui, MD
- Telefonnummer: 8615810348817
- E-post: 1250167892@qq.com
-
Kontakt:
- Yang Tao, MD
- Telefonnummer: 8618610358576
- E-post: tsmcyt@163.com
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Chronic thromboembolic pulmonary hypertension patients admitted in hospital.
Beskrivning
Inclusion Criteria:
- diagnosed with CTEPH according to ESC Guidelines (1) Mean PAP ≥ 25mmHg at rest; or if mean PAP < 25mmHg at rest, have exercise limitations from chronic thromboembolic disease (2)Abnormal ventilation perfusion lung scanning (VQ) scan, pulmonary angiogram, computer tomographic pulmonary angiogram, or magnetic resonance pulmonary angiogram confirming chronic thromboembolic disease as recommended by standard guidelines
- Treatment with anticoagulation for ≥ 3 months before diagnosis of CTEPH
- Not amenable to pulmonary endarterectomy
- Willing to provide informed consent
Exclusion Criteria:
- Patients unwilling or unable to provide written consent for participation in the study.
- Impossible to follow up.
Studieplan
Hur är studien utformad?
Designdetaljer
- Observationsmodeller: COHORT
- Tidsperspektiv: PROSPECTIVE
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Incidence of Treatment-Emergent Adverse Events of BPA procedure.
Tidsram: From initiation of BPA to 3-12 months after last session
|
Surveillance of complications including: vessel injury, desaturation, cough, mild hemoptysis (<50ml), severe hemoptysis (>50ml), reperfusion pulmonary injury, death. |
From initiation of BPA to 3-12 months after last session
|
|
Change of Pulmonary artery pressure in mmHg caused by series of BPA.
Tidsram: From initiation of BPA to 3-12 months after last session
|
Pulmonary artery pressure in mmHg is obtained by right cardiac catheterization. |
From initiation of BPA to 3-12 months after last session
|
|
Change of Pulmonary vascular resistance (PVR) in Wood U caused by series of BPA.
Tidsram: From initiation of BPA to 3-12 months after last session
|
Pulmonary vascular resistance (PVR) in Wood U is obtained by right cardiac catheterization. |
From initiation of BPA to 3-12 months after last session
|
|
Change of cardiac index (CI) in L/m^2 caused by series of BPA.
Tidsram: From initiation of BPA to 3-12 months after last session
|
Cardiac index (CI) in L/m^2 is obtained by right cardiac catheterization. |
From initiation of BPA to 3-12 months after last session
|
|
Change of World Health Organization (WHO) functional capacity classification caused by series of BPA.
Tidsram: From initiation of BPA to 3-12 months after last session
|
World Health Organization is obtained from electronic medical records. |
From initiation of BPA to 3-12 months after last session
|
|
Change of six minutes walk distance in meter caused by series of BPA.
Tidsram: From initiation of BPA to 3-12 months after last session
|
World Health Organization is obtained from electronic medical records. |
From initiation of BPA to 3-12 months after last session
|
|
Change of N-terminal B-type natriuretic peptide in pg/ml caused by series of BPA.
Tidsram: From initiation of BPA to 3-12 months after last session
|
World Health Organization is obtained from electronic medical records. |
From initiation of BPA to 3-12 months after last session
|
|
Change of Peak VO2/kg in ml/min/kg caused by series of BPA.
Tidsram: From initiation of BPA to 3-12 months after last session
|
Peak VO2/kg in ml/min/kg is obtained by cardiopulmonary exercise test. |
From initiation of BPA to 3-12 months after last session
|
|
Change of diffusing capacity for carbon monoxide caused by series of BPA.
Tidsram: From initiation of BPA to 3-12 months after last session
|
diffusing capacity for carbon monoxide in % is obtained from pulmonary function test |
From initiation of BPA to 3-12 months after last session
|
|
Change of fibroblast activation protein inhibitor expression after BPA
Tidsram: From initiation of BPA to 3-12 months after last session
|
Change of fibroblast activation protein inhibitor expression after BPA |
From initiation of BPA to 3-12 months after last session
|
Samarbetspartners och utredare
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- BPA registry
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .